Pharma & Bio
Technology
Biotech Stocks Rise Along with Stock Market Rebound… Orum Therapeutics, Inc. Soars 18% [Biotech Spotlight]
On the 31st, domestic pharmaceutical and biotech stocks showed a broadly strong performance, buoyed by a market rebound. Although there were quite a few stocks without any clear individual catalysts, …
Technology
Deciding the Outcome Outside the Lab… RA and BD: The “Highly Sought-After” Professionals in the Pharmaceutical and Biotech Sectors
(Graphic: ChatGPT)
When it comes to the workforce that determines the competitiveness of pharmaceutical and biotech companies, researchers are cited as the most critical. This is because new dru…
Lifestyle
[The Biomarker Money Game] “Liquid Biopsy,” Essential for Precision Medicine, Also Used in New Drug Development… Commercial Potential on the Rise
Liquid biopsy—a method of diagnosing cancer using only bodily fluids such as blood—has established itself as an essential technology in precision medicine and is expanding its scope of application to …
Technology
SkyLabs Aims for KOSDAQ… The Global Bidding War for K-Bio Contracts Unfolds in Seoul [Bio Monthly Roundup]
(Graphic: E-Daily Reporter Kim Jeong-hoon)
In August, the major events in South Korea’s pharmaceutical and biotech industry include the KOSDAQ listing of digital healthcare company SkyLabs and a s…
Technology
Targeting Niche Markets in U.S. Big Tech… A Look at K-SleepTech Companies Aiming for Precision Diagnostics
"Sleep accounts for one-third of our lives. Sleep diagnostics, which were previously only available in hospitals, are now coming into our bedrooms."As noted by Yoon In-young, a professor in the Depart…
Lifestyle
Will Investor Sentiment Return Amid the Semiconductor Market Correction? KMPHARMACEUTICAL Co.,Ltd. and LEMON COMPANY LIMITED Hit Daily Price Limits [Bio Market Watch]
As the domestic securities market has recently entered a period of consolidation for semiconductor and key information technology (IT) stocks, investor sentiment is rapidly shifting back toward the ph…
Lifestyle
Will Investment Sentiment Return to the Biotech Sector Amid a Tech Correction? KM Pharmaceutical and Lemon Healthcare Hit the Daily Price Limit [K-Bio Pulse]
As the domestic stock market has recently entered a lull centered on semiconductors and key Information Technology (IT) stocks, investment sentiment is rapidly shifting back to the pharmaceutical and …
Technology
SAMSUNG BIOLOGICS Sees Strong Momentum in the Second Half... How Much Will It Rebound?
SAMSUNG BIOLOGICS(207940)expressed confidence that its order intake, which remained at around $400 million in the first half of this year, will rebound significantly in the second half. This is not me…
Technology
Inverse ETFs Dominate the Bear Market [K-Bio Pulse]
On July 29, South Korea’s domestic stock market continued to weaken, causing inverse exchange-traded funds (ETFs) tracking the KOSDAQ’s decline to dominate the list of top gainers. More than half of t…
Technology
[Bio Spotlight] A Bear Market Where Only Inverse Funds Thrived… T&R Biofab Co., Ltd. and Lemon Healthcare Held Steady Thanks to Earnings and Technology
On the 29th, as the domestic stock market once again failed to escape a downtrend, inverse exchange-traded funds (ETFs) betting on a decline in the KOSDAQ index swept the top ranks in terms of returns…